About
Nitric Oxide-emitting Devices
Areas of Focus
Categories
Uncategorized Medical DeviceNJ, NY, PA
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
2
As Collaborator
7
Total Enrollment
3,894
By Phase
PHASE2: 1NA: 2
By Status
UNKNOWN: 5COMPLETED: 3RECRUITING: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT03728829Collaborator
Targeted Next Generation Sequencing for the Efficacy of Trastuzumab Neoadjuvant Chemotherapy in Breast Cancer
N/AUnknown
100 participants
Started: Jul 31, 2021 · Completed: Dec 31, 2022
NCT04445532Collaborator
Hepatobiliary Tumors Tissue Samples Acquisition
N/AUnknown
450 participants
Started: Oct 11, 2020 · Completed: Jun 1, 2025
NCT03997747Collaborator
Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OS
N/ACompleted
38 participants
Started: Aug 13, 2019 · Completed: Dec 1, 2021
NCT04289974Collaborator
Predicted Biomarkers of CDK4/6 Inhibitors (Palbociclib) in ER-positive Metastasis Breast Cancer
N/AUnknown
100 participants
Started: Feb 14, 2019 · Completed: Apr 30, 2022
NCT03831828Collaborator
Correlation of Gene Status and Clinical Outcomes in ESCC
N/AUnknown
46 participants
Started: Dec 26, 2018 · Completed: Apr 1, 2019
Funding History (1)
D
Nov 7, 2018
Locations (1)
Headquarters
Princeton, NJ, United States
Map
Loading map...